Skip to main content
Tech.euFundingExplorerBeta

Chord Therapeutics

Exited

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.

Chord Therapeutics has raised €14M across 1 funding round from 1 investor, most recently a Series A round in Oct 2020. Based in Geneva, Switzerland; founded 2014; active in Healthtech. Acquired by Merck in 2021. Data as of 28 Oct 2026.

Geneva, SwitzerlandFounded 2014www.chordtherapeutics.com ↗
Healthtech
← All companies
Total raised
€14M
€13,560,471
Funding rounds
1
Investors
1
distinct backers
Active since
2020-10
latest 2020-10

Funding by year

EUR raised per year
Chord Therapeutics — funding by year — interactive chart.
Data table
Chord Therapeutics — funding by year
2020€14M

Funding rounds

1 round
DateStageAmountInvestors
2020-10-13Series A€14MOmega FundsView deal →

Exit

Type
acquisition
Date
Dec 2021
Value
—
Acquiror
Merck (United States of America)

Investors

1
Omega Funds

Related news

Similar companies

same sector or country

Global coverage: FundingData